HDAC9 and cancer: Shao et al. [68] also noticed that histone deacetylase (HDAC) inhibitors, both butyrate and suberoylanilide hydroxamic acid (SAHA), can induce apoptosis and caspase-independent autophagic cell death in several human cancer cells.